United Pharm (033270) — Capital Reinvestment Ratio
United Pharm (033270) has a Capital Reinvestment Ratio of 0.71x as of March 2026, meaning it reinvests 1% of its operating cash flow (₩35.58 Billion) in capital expenditures (₩25.34 Billion). Check United Pharm tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
United Pharm Capital Reinvestment Ratio (2011–2025)
This chart tracks United Pharm's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see United Pharm cash flow conversion.
Annual Capital Reinvestment Ratio for United Pharm (2011–2025)
Year-by-year Capital Reinvestment Ratio for United Pharm from 2011 to 2025. See United Pharm free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | ₩51.14 Billion | ₩25.14 Billion | ▼ -37.9% |
| 2024 | 0.79x | ₩26.79 Billion | ₩21.22 Billion | ▲ +25.9% |
| 2023 | 0.63x | ₩49.77 Billion | ₩31.31 Billion | ▲ +65.8% |
| 2022 | 0.38x | ₩63.78 Billion | ₩24.21 Billion | ▲ +30.8% |
| 2021 | 0.29x | ₩44.09 Billion | ₩12.79 Billion | ▼ -14.5% |
| 2020 | 0.34x | ₩36.96 Billion | ₩12.55 Billion | ▼ -34.5% |
| 2019 | 0.52x | ₩38.15 Billion | ₩19.76 Billion | ▲ +10.1% |
| 2018 | 0.47x | ₩36.86 Billion | ₩17.35 Billion | ▼ -52.8% |
| 2017 | 1.00x | ₩27.68 Billion | ₩27.59 Billion | ▲ +125.1% |
| 2016 | 0.44x | ₩30.02 Billion | ₩13.29 Billion | ▲ +17.3% |
| 2014 | 0.38x | ₩21.31 Billion | ₩8.05 Billion | ▼ -40.8% |
| 2013 | 0.64x | ₩18.97 Billion | ₩12.11 Billion | ▲ +14.8% |
| 2012 | 0.56x | ₩21.88 Billion | ₩12.16 Billion | ▲ +2.6% |
| 2011 | 0.54x | ₩27.62 Billion | ₩14.95 Billion | — |